Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021
- 1 August 2021
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 83 (2) , 237-279
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workersJournal of Infection, 2021
- Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workersJournal of Infection, 2021
- Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021Eurosurveillance, 2021
- Covid-19: Is vaccination roll out reducing cases and deaths in the UK?BMJ, 2021
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonThe Lancet Infectious Diseases, 2020